Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Jayson

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 23, 2019
A novel discharge pathway for patients with advanced cancer requiring home parenteral nutritionA Bond, A Teubner, M Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.
British Journal of Cancer|June 16, 2011
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6J P B O'Connor, C J Rose, A Jackson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2006
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinomaD D Rosa, A Clamp, S Mullamitha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board, C T P H Bruijns, A E Pronk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2010
Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapyC L Mitchell, J P B O'Connor, A Jackson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2016
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UKL Khoja, K Nolan, R Mekki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2004
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volumeG C Jayson, G J M Parker, S Mullamitha, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2010
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamicsClaire L Mitchell, J P B O'Connor, C Roberts, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 23, 2019
A novel discharge pathway for patients with advanced cancer requiring home parenteral nutritionA Bond, A Teubner, M Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.
British Journal of Cancer|June 16, 2011
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6J P B O'Connor, C J Rose, A Jackson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 30, 2006
The interval from surgery to chemotherapy in the treatment of advanced epithelial ovarian carcinomaD D Rosa, A Clamp, S Mullamitha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board, C T P H Bruijns, A E Pronk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2010
Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapyC L Mitchell, J P B O'Connor, A Jackson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2016
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UKL Khoja, K Nolan, R Mekki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2004
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volumeG C Jayson, G J M Parker, S Mullamitha, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2010
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamicsClaire L Mitchell, J P B O'Connor, C Roberts, et al.
Pageof 7